Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Launched by DUKE UNIVERSITY · Dec 6, 2012
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a special imaging test called cardiac magnetic resonance (CMR) can detect heart problems in patients who have sarcoidosis, a condition where clusters of inflammatory cells can affect various organs, including the heart. The main goal is to see if CMR can help identify if the heart is affected in patients who already have a confirmed diagnosis of sarcoidosis and are suspected of having heart involvement.
To participate, patients need to have a biopsy that confirms they have sarcoidosis and should be suspected of having it in their heart. This trial is open to adults aged 65 to 74, and both men and women can join. Participants will undergo CMR in addition to their regular check-ups to see how well this imaging technique can help in understanding their heart condition. It’s important to note that individuals who cannot safely undergo an MRI (the type of scan used in CMR) will not be eligible for the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Biopsy proven sarcoidosis
- • Suspected cardiac sarcoidosis
- Exclusion Criteria:
- • Contraindication to MRI
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Raymond J Kim, MD
Principal Investigator
Duke Cardiovascular Magnetic Resonance Center, Duke University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials